Renovion Announces Positive Top-Line Results from Phase 2 CLIMB Study of ARINA-1 (RVN-301) in Patients with Non-Cystic Fibrosis Bronchiectasis

News published by Renovion Inc. concerning ARINA-1, a nebulized therapy administered via an optimized investigational eFlow^® Technology nebulizer.
 

Read the press release